Diazepam NHS ester
Product key features
- Amine-reactive NHS ester – Enables efficient & selective conjugation to primary amines, forming stable amide bonds under mild aqueous conditions.
- Biologically active diazepam core – Preserves the structural and pharmacological properties of diazepam, including affinity for GABA_A receptors.
- Ideal for neuropharmacological applications – Supports the development of molecular probes, affinity ligands, & receptor-binding assays.
Product description
Diazepam NHS ester is a chemically activated derivative of diazepam incorporating an N-hydroxysuccinimide (NHS) ester functional group for targeted bioconjugation. The NHS ester reacts selectively with primary amines under physiological to slightly basic conditions (pH 7.0–8.5), enabling the formation of stable amide bonds with proteins, peptides, and other amine-containing biomolecules. The diazepam scaffold remains intact, preserving its affinity for GABA_A receptors and related pharmacological targets. This reagent is well-suited for the development of diazepam-functionalized affinity ligands, targeted delivery systems, and molecular probes for receptor-binding assays and imaging applications. Its compatibility with aqueous systems and high coupling efficiency make Diazepam NHS ester a useful tool in neuropharmacological research, investigating benzodiazepine mechanisms, receptor-ligand interaction studies, and the development of functionalized delivery platforms or diagnostic probes.
Product family
Name | Excitation (nm) | Emission (nm) | Extinction coefficient (cm -1 M -1) | Quantum yield | Correction Factor (260 nm) | Correction Factor (280 nm) |
Cy2DIGE NHS ester | 492 | 508 | 150000 | 0.120 | 0.08 | 0.15 |
Cy3B NHS ester | 560 | 571 | 1200001 | 0.581 | 0.048 | 0.069 |
Cy3DIGE NHS ester | 555 | 569 | 1500001 | 0.151 | 0.07 | 0.073 |
Cy5DIGE NHS ester | 651 | 670 | 2500001 | 0.271, 0.42 | 0.02 | 0.03 |
CypHer5E NHS Ester | 643 | 660 | - | - | - | - |
CypHer7E NHS Ester | 748 | 769 | - | - | - | - |
QXY21 NHS ester [equivalent to QSY-21 NHS ester] | - | - | 890001 | - | - | 0.32 |
QXY7 NHS ester [equivalent to QSY-7 NHS ester] | - | - | 900001 | - | - | 0.22 |
XFD350 NHS Ester *Same Structure to Alexa Fluor™ 350 NHS Ester* | 343 | 441 | 19000 | - | 0.25 | 0.19 |
Show More (14) |
References
Authors: Su, Liu and Lai, Xiaocui and Zhang, Ganggang and Liu, Cong and He, Weihua and Zhang, Gan and Lai, Weihua and Deng, Shengliang
Journal: Analytica chimica acta (2025): 343700
Authors: Jimenez, Jessica A and McCoy, Eric S and Lee, David F and Zylka, Mark J
Journal: F1000Research (2023): 234
Authors: Rezaee, Elham and Ahmadi, Fatemeh and Shabaninia, Mahsa and Khoramjouy, Mona and Azizi Farsani, Zahra and Shahhosseini, Soraya and Tabatabai, Sayyed Abbas and Faizi, Mehrdad
Journal: EXCLI journal (2023): 250-262
Authors: Pilli, Nageswara R and Narayanasamy, Suresh and Xu, Lin and Chockalingam, Ashok and Shea, Katherine I and Stewart, Sharron and Rouse, Rodney and Patel, Vikram and Matta, Murali K
Journal: RSC advances (2020): 886-896
Authors: Toolabi, Mahsa and Khoramjouy, Mona and Aghcheli, Ayoub and Ayati, Adileh and Moghimi, Setareh and Firoozpour, Loghman and Shahhosseini, Soraya and Shojaei, Rouhallah and Asadipour, Ali and Divsalar, Kouros and Faizi, Mehrdad and Foroumadi, Alireza
Journal: Archiv der Pharmazie (2020): e2000066